{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
prnewswire

Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5

  • Press Release
  • Source: Cell Therapeutics, Inc.
  • On 1:30 am EST, Monday November 2, 2009

SEATTLE, Nov. 2 /PRNewswire-FirstCall/ -- On Thursday, November 5, 2009, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the Company's 2009 third quarter financial results.

Related Quotes

SymbolPriceChange
CTIC1.11+0.01
Chart for Cell Therapeutics, Inc.
{"s" : "ctic","k" : "c10,l10,p20,t10","o" : "","j" : ""}

    Conference Call Numbers
    Thursday, November 5
    8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time
    1-877-941-6010 (US Participants)
    1-1-480-629-9772 (International)

    Call-back numbers for post-call listening available at 10:30 a.m. Eastern:
    1-800-406-7325 (US Participants)
    1-303-590-3030 (International)
    Passcode: 4168724#

    Live audio webcast at www.celltherapeutics.com will be archived for
    post-call listening approximately two hours after the call ends.

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: deramian@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors

Sponsored Links

Copyright © 2009 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.